Prognostic index to identify patients who may not benefit from whole brain radiotherapy for multiple brain metastases from lung cancer

Journal of Medical Imaging and Radiation Oncology

Volumn 54, Issue 1, 2010, Pages 69-75

  Sundaresan, P ^a   Yeghiaian Alvandi, R ^a   Gebski, V ^b  

^a WESTMEAD HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Brain metastases; Lung cancer; Prognostic index; WBRT; Whole brain radiotherapy

Indexed keywords

ADULT; ARTICLE; BRAIN METASTASIS; BRAIN RADIATION; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; EVALUATION; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; PALLIATIVE THERAPY; PATIENT IDENTIFICATION; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; VALIDATION PROCESS;

AGED; BRAIN NEOPLASMS; DECISION SUPPORT TECHNIQUES; FEMALE; HUMANS; LOGISTIC MODELS; LUNG NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PATIENT SELECTION; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77749249687     PISSN: 17549477     EISSN: 17549485     Source Type: Journal    
DOI: 10.1111/j.1754-9485.2010.02140.x     Document Type: Article

References (31)

1. Walker AE, Robins M, Weinfeld FD. Epidemiology of brain tumours. The national survey of intracranial neoplasms. Neurology 1985 35 : 219 226.
2. Barnholz-Sloan JS, Sloan AE, Davis FG, Vigneau FD, Lai P, Sawaya RE. Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System. J Clin Oncol 2004 22 : 2865 2872.
3. Schouten LJ, Rutten J, Huveneers HA, Twijnstra A. Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma. Cancer 2002 94 (10 2698 2705.
4. Pease NJ, Edwards A, Moss LJ. Effectiveness of whole brain radiotherapy in the treatment of brain metastases: a systematic review. Palliat Med 2005 19 : 288 299.
5. Tsao MN, Lloyd N, Wong R, Chow E, Rakovitch E, Laperriere N. Whole brain radiotherapy for the treatment of multiple brain metastases. Cochrane Database Syst Rev 2006 2 : CD003869.
6. Lagerwaard FJ, Levendag PC, Nowak PJ, Eijkenboom WM, Hanssens PE, Schmitz PI. Identification of prognostic factors in patients with brain metastases: a review of 1292 patients. Int J Radiat Oncol Biol Phys 1999 43 (4 795 803.
7. Bezjak A, Adam J, Barton R et al. Symptom response after palliative radiotherapy for patients with brain metastases. Eur J Cancer 2002 38 (4 487 496.
8. Chow E, Davis L, Holden L, Tsao M, Danjoux C. Prospective assessment of patient-related symptoms following whole brain radiotherapy for brain metastases. J Pain Symptom Manage 2005 30 (1 18 23.
9. Posner JB. Management of central nervous system metastases. Semin Oncol 1977 4 : 81 91.
10. Zimm S, Wampler GL, Stablein D. Intracerebral metastases in solid tumor patients: natural history and results of treatment. Cancer 1981 48 : 384 394.
11. Katz HR. The relative effectiveness of radiation therapy, corticosteroids and surgery in the management of melanoma metastatic to the central nervous system. Int J Radiat Oncol Biol Phys 1981 7 : 897 906.
12. Patchell R, Tibbs P, Walsh J et al. A randomized trial of surgery in the treatment of single metastasis to the brain. N Engl J Med 1990 322 : 494 499.
13. Vecht C, Haaxma-Reich H, Noordijk E et al. Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery. Ann Neurol 1993 33 : 583 590.
14. Sperduto P, Andrews D. A phase 3 trial comparing whole brain irradiation alone versus whole brain irradiation plus stereotactic radiosurgery for patients with one to three brain metastases. Int J Radiat Oncol Biol Phys 2003 54 : 3.
15. Andrews DW, Scott CB, Sperduto PW et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomized trial. Lancet 2004 363 : 1665 1672.
16. Gerrard GE, Prestwich RJ, Edwards A et al. Investigating the palliative efficacy of whole brain radiotherapy for patients with multiple brain metastases and poor prognostic features. Clin Oncol (R Coll Radiol) 2003 15 : 422 428.
17. Hoskin PJ. Case selection in the management of cerebral metastases. Clin Oncol (R Coll Radiol) 2003 15 : 420 421.
18. Bezjak A, Adam J, Panzarella T et al. Radiotherapy for brain metastases: defining palliative response. Radiother Oncol 2001 61 (1 71 6.
19. Vigano A, Dorgan M, Buckingham J, Bruera E, Suarez-Almazor ME. Survival prediction in terminal cancer patients: a systematic review of the medical literature. Palliat Med 2000 14 : 363 374.
20. Reuben DB, Mor V, Hiris J. Clinical symptoms and length of survival in patients with terminal cancer. Arch Intern Med 1988 148 : 1586 1591.
21. Medical Research Council (MRC), Trans Tasman Radiation Oncology Group (TROG). QUARTZ - Quality of Life after Radiotherapy Steroids Trial. Medical Research Council Clinical Trials Unit, 2007.
22. Christakis NA, Lamont EB. Extent and determinants of error in doctors' prognoses in terminally ill patients: prospective cohort study. Br Med J 2000 320 : 469 473.
23. Gaspar L, Scott C, Rotman M et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 1997 37 (4 745 751.
24. Videtic GM, Adelstein DJ, Mekhail TM et al. Validation of the RTOG recursive partitioning analysis (RPA) classification for small-cell lung cancer-only brain metastases. Int J Radiat Oncol Biol Phys 2007 67 (1 240 243.
25. Rodrigues P, de Brouwer P, Raaymakers E. Brain metastases and non-small cell lung cancer. Prognostic factors and correlation with survival after irradiation. Lung Cancer 2001 32 : 129 136.
26. Sperduto PW, Berkey B, Gaspar LE, Mehta M, Curran W. A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1960 patients in the RTOG database. Int J Radiat Oncol Biol Phys 2008 70 (2 510 514.
27. Ryan G, Ball D, Smith J. Treatment of brain metastases from primary lung cancer. Int J Radiat Oncol Biol Phys 1995 31 (2 272 278.
28. Broadbent A, Hruby G, Tin M, Jackson M, Firth I. Survival following whole brain radiation treatment for cerebral metastases: an audit of 474 patients. Radiother Oncol 2004 71 (3 259 265.
29. Kepka L, Cieslak E, Bujko K, Fijuth J, Wierzchowski M. Results of the whole brain radiotherapy for patients with brain metastases from lung cancer: the RTOG RPA intra-classes analysis. Acta Oncologica 2005 44 (4 389 398.
30. Lock M, Chow E, Pond G et al. Prognostic factors in brain metastases: can we determine patients who do not benefit from whole brain radiotherapy? Clin Oncol (R Coll Radiol) 2004 16 : 332 338.
31. Gaspar LE, Charnskey K, Albain KS et al. Time from treatment to subsequent diagnosis of brain metastasis in stage III NSCLC: a retrospective review by the Southwest Oncology Group. J Clin Oncol 2005 23 (13 2955 2961.